These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 9884371)
1. Gene targets and approaches for raising HDL. van Vlijmen BJ; Herz J Circulation; 1999 Jan 5-12; 99(1):12-4. PubMed ID: 9884371 [No Abstract] [Full Text] [Related]
2. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice]. Li H; Gu S; She M Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II. Pastier D; Dugué S; Boisfer E; Atger V; Tran NQ; van Tol A; Chapman MJ; Chambaz J; Laplaud PM; Kalopissis AD Biochemistry; 2001 Oct; 40(41):12243-53. PubMed ID: 11591143 [TBL] [Abstract][Full Text] [Related]
4. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of human apolipoprotein AI and high-density lipoprotein by fenofibrate in hapoAI and hapoAI-CIII-AIV transgenic mice. Srivastava RA; He S; Newton RS Biochim Biophys Acta; 2011 Feb; 1811(2):76-83. PubMed ID: 21081177 [TBL] [Abstract][Full Text] [Related]
6. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Rubin EM; Ishida BY; Clift SM; Krauss RM Proc Natl Acad Sci U S A; 1991 Jan; 88(2):434-8. PubMed ID: 1703299 [TBL] [Abstract][Full Text] [Related]
7. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism. Srivastava RA; Srivastava N; Averna M Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832 [TBL] [Abstract][Full Text] [Related]
8. Homocysteine and cardiovascular disease: is HDL the link? Barter PJ; Rye KA Circ Res; 2006 Sep; 99(6):565-6. PubMed ID: 16973911 [No Abstract] [Full Text] [Related]
9. Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin. Mangat R; Borthwick F; Haase T; Jacome M; Nelson R; Kontush A; Vine DF; Proctor SD FASEB J; 2018 Mar; 32(3):1602-1612. PubMed ID: 29183962 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525 [TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800 [TBL] [Abstract][Full Text] [Related]
12. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656 [TBL] [Abstract][Full Text] [Related]
14. Role of phospholipid transfer protein in high-density lipoprotein metabolism: insights from studies in transgenic mice. Van Tol A; Jauhiainen M; De Crom R; Ehnholm C Int J Tissue React; 2000; 22(2-3):79-84. PubMed ID: 10937357 [No Abstract] [Full Text] [Related]
15. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice. Hayek T; Ito Y; Azrolan N; Verdery RB; Aalto-Setälä K; Walsh A; Breslow JL J Clin Invest; 1993 Apr; 91(4):1665-71. PubMed ID: 8473509 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV. Kalopissis AD; Chambaz J Int J Tissue React; 2000; 22(2-3):67-78. PubMed ID: 10937356 [TBL] [Abstract][Full Text] [Related]
17. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Chajek-Shaul T; Hayek T; Walsh A; Breslow JL Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6731-5. PubMed ID: 1907375 [TBL] [Abstract][Full Text] [Related]
18. [The implantation of the human ApoAI gene into aged animals]. Frol'kis VV; Kordium VA; Bogatskaia LN; Novikova SN; Shul'zhenko VN; Kostetskiĭ IE; Potapenko RI; Sabko VE; Mozzhukhina TG; Paramonova GI Dokl Akad Nauk SSSR; 1991; 316(5):1264-7. PubMed ID: 1909232 [No Abstract] [Full Text] [Related]
19. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932 [TBL] [Abstract][Full Text] [Related]